UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
BMC nephrology, ISSN 1471-2369, 10/2015, Volume 16, Issue 1, pp. 158 - 158
Prospective | Dose adjustment | Renal impairment | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prospective Studies | Spironolactone - administration & dosage | Humans | Middle Aged | Fluconazole - administration & dosage | Antihypertensive Agents - administration & dosage | Male | Young Adult | Drug Dosage Calculations | Aged, 80 and over | Adult | Female | Cimetidine - administration & dosage | Enalapril - administration & dosage | Pharmaceutical Preparations - administration & dosage | Medication Errors | Severity of Illness Index | Diuretics - administration & dosage | Vancomycin - administration & dosage | Cross-Sectional Studies | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Hospitalization | Acute Kidney Injury - physiopathology | Anti-Arrhythmia Agents - administration & dosage | Creatinine - urine | Renal Insufficiency, Chronic - physiopathology | Anti-Ulcer Agents - administration & dosage | Gout Suppressants - administration & dosage | Drug Prescriptions - statistics & numerical data | Allopurinol - administration & dosage | Digoxin - administration & dosage | Adolescent | Ceftazidime - administration & dosage | Creatinine - blood | Aged | Anti-Bacterial Agents - administration & dosage | Antifungal Agents - administration & dosage | Ethiopia | Drugs | Prescribing | Medical research | Hospital patients | Prescription writing | Analysis | Medicine, Experimental | Medical care | Quality management | Index Medicus
Journal Article
Journal of cardiovascular pharmacology, ISSN 0160-2446, 05/2019, Volume 73, Issue 5, pp. 307 - 315
Cardiac & Cardiovascular Systems | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Fluid Therapy | Kidney - drug effects | Humans | Risk Factors | Treatment Outcome | Gout Suppressants - adverse effects | Acute Kidney Injury - physiopathology | Acute Kidney Injury - prevention & control | Incidence | Randomized Controlled Trials as Topic | Gout Suppressants - therapeutic use | Allopurinol - therapeutic use | Contrast Media - adverse effects | Allopurinol - adverse effects | Acute Kidney Injury - chemically induced | Acute Kidney Injury - epidemiology | Network Meta-Analysis | Kidney - physiopathology | Cytoprotection | Complications and side effects | Dosage and administration | Kidney diseases | Angiography | Allopurinol | Risk factors | Index Medicus
Journal Article
Journal of clinical pharmacy and therapeutics, ISSN 0269-4727, 08/2019, Volume 44, Issue 4, pp. 525 - 533
tumour lysis syndrome | hyperuricemia | febuxostat | meta‐analysis | allopurinol | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Febuxostat - adverse effects | Gout Suppressants - administration & dosage | Tumor Lysis Syndrome - prevention & control | Animals | Allopurinol - administration & dosage | Humans | Allopurinol - adverse effects | Tumor Lysis Syndrome - blood | Uric Acid - blood | Gout Suppressants - adverse effects | Febuxostat - administration & dosage | Prevention | Medicine, Experimental | Medical research | Uric acid | Analysis | Tumors | Scientific papers | Cytolysis | Acids | Allopurinol | Lysis | Clinical trials | Search engines | Safety | Incidence | Index Medicus
Journal Article
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, ISSN 1570-0232, 09/2014, Volume 966, pp. 127 - 131
Physical exercise | Metabolomics | GC–MS | Allopurinol | Metabonomics | GC-MS | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Gas Chromatography-Mass Spectrometry - methods | Reproducibility of Results | Rats, Wistar | Metabolome - physiology | Rats | Male | Biomarkers - blood | Physical Conditioning, Animal - physiology | Metabolomics - methods | Animals | Allopurinol - administration & dosage | Analysis of Variance | Metabolome - drug effects | Allopurinol - pharmacology | Sports sciences | Exercise | Metabolites | Investigations | Oxidases | Care and treatment | Oxalic acid | Gout | Amino acids | Oxalates | Index Medicus | Separation | Free radicals | Statistical analysis | Inhibitors | Samples | Exhaustion | Statistical methods
Journal Article
Archives of disease in childhood. Fetal and neonatal edition, ISSN 1359-2998, 05/2015, Volume 100, Issue 3, pp. F216 - F223
Life Sciences & Biomedicine | Pediatrics | Science & Technology | Dinoprost - blood | Double-Blind Method | Maternal-Fetal Exchange | Humans | Male | Aldehydes - blood | Enzyme Inhibitors - therapeutic use | S100 Calcium Binding Protein beta Subunit - blood | Pregnancy | Allopurinol - therapeutic use | Oxypurinol - blood | Ketones - blood | Fetal Blood - chemistry | Fetal Hypoxia - drug therapy | Adult | Female | Dinoprost - analogs & derivatives | Allopurinol - blood | Xanthine Oxidase - antagonists & inhibitors | Complications and side effects | Care and treatment | Usage | Brain-damaged children | Allopurinol | Clinical trials | Dosage and administration | Fetal anoxia | Studies | Free radicals | Brain research | Womens health | Rodents | Fetuses | Brain damage | Hypoxia | Umbilical cord | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue 6, pp. 1074 - 1080
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Triazoles - administration & dosage | Double-Blind Method | Humans | Middle Aged | Gout - drug therapy | Male | Treatment Outcome | Gout Suppressants - administration & dosage | Thioglycolates - administration & dosage | Allopurinol - administration & dosage | Adult | Female | Drug Therapy, Combination | Clinical trials | Care and treatment | Usage | Dosage and administration | Allopurinol | Gout | Index Medicus | Clinical and Epidemiological Research | Inflammation | Treatment | Pharmacokinetics | 1506
Journal Article
7.
Full Text
pH-Dependent 5-Aminosalicylates Releasing Preparations Do Not Affect Thiopurine Metabolism
Digestion, ISSN 0012-2823, 11/2019, Volume 100, Issue 4, pp. 238 - 246
Original Paper | Mesalazine | Crohn's disease | Ulcerative colitis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Immunosuppressive Agents - pharmacokinetics | Middle Aged | Male | Guanine Nucleotides - pharmacokinetics | Inflammatory Bowel Diseases - metabolism | Young Adult | Thionucleotides - administration & dosage | Drug Interactions | Time Factors | Guanine Nucleotides - administration & dosage | Adult | Female | Retrospective Studies | Mercaptopurine - analogs & derivatives | Immunosuppressive Agents - administration & dosage | Mercaptopurine - pharmacokinetics | Mesalamine - administration & dosage | Inflammatory Bowel Diseases - drug therapy | Administration, Oral | Mesalamine - pharmacokinetics | Mercaptopurine - administration & dosage | Inflammatory Bowel Diseases - blood | Allopurinol - administration & dosage | Adolescent | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Drug Liberation | Thionucleotides - pharmacokinetics | Aged | Allopurinol - pharmacokinetics | Hydrogen-Ion Concentration | Index Medicus
Journal Article
Journal of clinical pharmacy and therapeutics, ISSN 0269-4727, 10/2017, Volume 42, Issue 5, pp. 642 - 645
teicoplanin | drug reaction with eosinophilia and systemic symptoms | allopurinol | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Vidarabine - analogs & derivatives | Gout Suppressants - adverse effects | Cytarabine - administration & dosage | Gout Suppressants - administration & dosage | Teicoplanin - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Teicoplanin - administration & dosage | Allopurinol - administration & dosage | Allopurinol - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Vidarabine - administration & dosage | Drug Hypersensitivity Syndrome - etiology | Anti-Bacterial Agents - administration & dosage | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Complications and side effects | Chemotherapy | Leukemia | Allopurinol | Dosage and administration | Eosinophilia | Cancer | Liver | Exanthema | Prophylaxis | Pruritus | Drug development | Hydrocortisone | Cytarabine | Dyspnea | Granulocyte colony-stimulating factor | Colony-stimulating factor | Drug dosages | Enzymes | Limbs | Edema | Alanine | Acute lymphatic leukemia | Hypersensitivity | Abnormalities | Case reports | Fever | Side effects | Fludarabine | Lysis | Alanine transaminase | Respiration | Erythema | Tumors
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 06/2009, Volume 68, Issue 6, pp. 892 - 897
KIDNEY-DISEASE | URATE | ATTACKS | MANAGEMENT | HYPERURICEMIA | THERAPY | PREVENTION | OSTEOARTHRITIS | ARTHRITIS | URIC-ACID | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Miscellaneous. Osteoarticular involvement in other diseases | Purines and pyrimidines (gout, hyperuricemia...) | Other metabolic disorders | Diseases of the osteoarticular system | Inflammatory joint diseases | Biological and medical sciences | Metabolic diseases | Medical sciences | Confidence Intervals | Prospective Studies | Humans | Middle Aged | Gout - drug therapy | Male | Dose-Response Relationship, Drug | Oxypurinol - blood | Drug-Related Side Effects and Adverse Reactions | Female | Uric Acid - blood | Gout - blood | Drug Administration Schedule | Uricosuric Agents - administration & dosage | Treatment Outcome | Gout Suppressants - adverse effects | Benzbromarone - administration & dosage | Gout Suppressants - administration & dosage | Gout Suppressants - therapeutic use | Allopurinol - therapeutic use | Benzbromarone - therapeutic use | Allopurinol - administration & dosage | Benzbromarone - adverse effects | Allopurinol - adverse effects | Uricosuric Agents - adverse effects | Aged | Patient Compliance | Uricosuric Agents - therapeutic use | Usage | Gout | Patient outcomes | Allopurinol | Dosage and administration | Drug therapy | Health aspects | Studies | Clinical medicine | Drug dosages | Success | Index Medicus
Journal Article
The American journal of medicine, ISSN 0002-9343, 2011, Volume 124, Issue 2, pp. 155 - 163
Internal Medicine | Treatment | Drug contraindication | Comorbidity | Gout | Quality of care | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Diseases of the osteoarticular system | Inflammatory joint diseases | Biological and medical sciences | Medical sciences | Epidemiology | Severity of Illness Index | Glucocorticoids - administration & dosage | Prevalence | Humans | Middle Aged | Uricosuric Agents - administration & dosage | Gout - drug therapy | Probenecid - administration & dosage | Colchicine - administration & dosage | Male | Gastroesophageal Reflux - epidemiology | Drug Prescriptions - standards | Contraindications | Gout Suppressants - administration & dosage | Renal Insufficiency, Chronic - epidemiology | Allopurinol - administration & dosage | Gout - epidemiology | Hepatitis, Chronic - epidemiology | Diabetes Mellitus - epidemiology | Aged, 80 and over | Female | Aged | Hypertension - epidemiology | Medical research | Rheumatism | Pharmacology | Drug therapy | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article